Photodynamic therapy for subretinal new vessels

Sungchul Lee, Jeong Hun Bae, Hyung Jun Koh, Sung Soo Kim, Oh Woong Kwon

Research output: Contribution to journalArticle

Abstract

Photodynamic therapy (PDT) involves the induction of endothelial cell death or occlusion of blood vessels. On the basis of this mechanism of action, PDT is used in the treatment of predominant classic choroidal neovascularization (CNV), if the classic component is over 50%, and in myopic CNV. This study describes 2 cases of distinctive, abnormal, large, subretinal new vessels that are thought to have originated from the choroids. Diminishment of the new vessels was observed following treatment with PDT.

Original languageEnglish
Pages (from-to)325-327
Number of pages3
JournalYonsei medical journal
Volume48
Issue number2
DOIs
Publication statusPublished - 2007 Apr 1

Fingerprint

Photochemotherapy
Choroidal Neovascularization
Choroid
Blood Vessels
Cell Death
Endothelial Cells
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, S., Bae, J. H., Koh, H. J., Kim, S. S., & Kwon, O. W. (2007). Photodynamic therapy for subretinal new vessels. Yonsei medical journal, 48(2), 325-327. https://doi.org/10.3349/ymj.2007.48.2.325
Lee, Sungchul ; Bae, Jeong Hun ; Koh, Hyung Jun ; Kim, Sung Soo ; Kwon, Oh Woong. / Photodynamic therapy for subretinal new vessels. In: Yonsei medical journal. 2007 ; Vol. 48, No. 2. pp. 325-327.
@article{50986f259ff34f36beb556d3ac89ebb5,
title = "Photodynamic therapy for subretinal new vessels",
abstract = "Photodynamic therapy (PDT) involves the induction of endothelial cell death or occlusion of blood vessels. On the basis of this mechanism of action, PDT is used in the treatment of predominant classic choroidal neovascularization (CNV), if the classic component is over 50{\%}, and in myopic CNV. This study describes 2 cases of distinctive, abnormal, large, subretinal new vessels that are thought to have originated from the choroids. Diminishment of the new vessels was observed following treatment with PDT.",
author = "Sungchul Lee and Bae, {Jeong Hun} and Koh, {Hyung Jun} and Kim, {Sung Soo} and Kwon, {Oh Woong}",
year = "2007",
month = "4",
day = "1",
doi = "10.3349/ymj.2007.48.2.325",
language = "English",
volume = "48",
pages = "325--327",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "2",

}

Lee, S, Bae, JH, Koh, HJ, Kim, SS & Kwon, OW 2007, 'Photodynamic therapy for subretinal new vessels', Yonsei medical journal, vol. 48, no. 2, pp. 325-327. https://doi.org/10.3349/ymj.2007.48.2.325

Photodynamic therapy for subretinal new vessels. / Lee, Sungchul; Bae, Jeong Hun; Koh, Hyung Jun; Kim, Sung Soo; Kwon, Oh Woong.

In: Yonsei medical journal, Vol. 48, No. 2, 01.04.2007, p. 325-327.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Photodynamic therapy for subretinal new vessels

AU - Lee, Sungchul

AU - Bae, Jeong Hun

AU - Koh, Hyung Jun

AU - Kim, Sung Soo

AU - Kwon, Oh Woong

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Photodynamic therapy (PDT) involves the induction of endothelial cell death or occlusion of blood vessels. On the basis of this mechanism of action, PDT is used in the treatment of predominant classic choroidal neovascularization (CNV), if the classic component is over 50%, and in myopic CNV. This study describes 2 cases of distinctive, abnormal, large, subretinal new vessels that are thought to have originated from the choroids. Diminishment of the new vessels was observed following treatment with PDT.

AB - Photodynamic therapy (PDT) involves the induction of endothelial cell death or occlusion of blood vessels. On the basis of this mechanism of action, PDT is used in the treatment of predominant classic choroidal neovascularization (CNV), if the classic component is over 50%, and in myopic CNV. This study describes 2 cases of distinctive, abnormal, large, subretinal new vessels that are thought to have originated from the choroids. Diminishment of the new vessels was observed following treatment with PDT.

UR - http://www.scopus.com/inward/record.url?scp=34248137935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248137935&partnerID=8YFLogxK

U2 - 10.3349/ymj.2007.48.2.325

DO - 10.3349/ymj.2007.48.2.325

M3 - Article

VL - 48

SP - 325

EP - 327

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 2

ER -